This is fantasting news for the German pharma and biotech landscape: Corporate powerhouses like Daiichi Sankyo US, Eli Lilly and Company and now, most recently, Sanofi are investing heavily in Germany, and thus strengthening Germany as a top-tier rated pharmaceutical location worldwide 💊 🌍 https://lnkd.in/euSGPr_D Let us know what you think - and if you’d like to talk to us at Taylor Wessing about any of this, we would be curious to hear your view & thougths. #TaylorWessing #Biotech #VentureCapital
Niclas von Woedtke’s Post
More Relevant Posts
-
Managing Principal at HED and #HED Board Member (March 2019-present)
The end of the last decade brought record highs in pharmaceutical M&A as larger companies turned again and again to young biotechs for innovation. That trend is on the upswing again. Here are the latest deals: https://ow.ly/Zkoh30sFwut #manda #biopharma #drugdevelopment #biotech #mergersandacquisitions
-
-
The end of the last decade brought record highs in pharmaceutical M&A as larger companies turned again and again to young biotechs for innovation. That trend is on the upswing again. Here are the latest deals: https://ow.ly/S1AQ30sFvJS #manda #biopharma #drugdevelopment #biotech #mergersandacquisitions
-
-
🌟 AUSTAR Pharma Conference 2024 Wrap-Up 🌟 Today, AUSTAR convened a thought-provoking seminar about automation and digitalization in the pharmaceutical field, and as we reflect on the day, it's clear our industry is ready for a new era of innovation and collaboration. The theme "Breaking Free, Rising Above" resonated strongly, gathering experts to discuss the pharmaceutical future. We connected with leaders and explored new paths together, addressing current challenges and mapping out a sustainable, prosperous future. It was a day of inspiring conversations, and we're thrilled about what's next. Let's continue to break through barriers and rise together in the pharmaceutical field. #AUSTARPharmaSummit #PharmaInnovation #FutureOfPharma
-
Patient Access Challenges Are Changing Pharma Investment Strategies https://lnkd.in/esWeKq83 - By Jennifer (Goldenberg) Klarer, M.Sc.Eng., The Dedham Group, and Dinesh Kannan Kabaleeswaran, MMIT (Managed Markets Insight & Technology) Pharmaceutical executives are facing a multitude of patient access hurdles driven by an increasingly complex, competitive market.
-
-
Customized Reports: Spain's Gateway to Global Pharma Intelligence Spain is harnessing the power of customized reports to leapfrog into global pharmaceutical leadership: • Local Insights, Global Impact: Leveraging unique Spanish market data to inform international strategies. •Collaborative Research: Spain's role in fostering global pharmaceutical research collaborations through data sharing. • Innovation Ecosystem: Supporting Spain's burgeoning biotech landscape with targeted, data-driven insights. #SpainFarma #CustomizedReports #MENA
-
The end of the last decade brought record highs in pharmaceutical M&A as larger companies turned again and again to young biotechs for innovation. That trend is on the upswing again. Here are the latest deals: https://ow.ly/ljjs30sFwzE #manda #biopharma #drugdevelopment #biotech #mergersandacquisitions
-
-
Maximising the benefits of Digitalisation and Artificial Intelligence for the Pharmaceutical sector is essential for businesses. That’s why PMTC Knowledge Day is bringing together leading experts in industry and academia to discuss how pharma is incorporating these advances into its operations. Dr Ian Jones, founder and CEO of InnoGlobal will speak about shaping the future of global (bio) pharma manufacturing through a 5.0 lens and and how organisations are best positioned to thrive in this space. Register now at https://lnkd.in/evNxMriw #Digitalisation #PMTCKnowledgeDay
-
-
𝐖𝐡𝐢𝐜𝐡 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐬𝐩𝐞𝐧𝐝𝐬 𝐭𝐡𝐞 𝐦𝐨𝐬𝐭? 🧪 R&D stands as a significant cost for all biopharma companies. Yet, I find it intriguing how the extent of this expenditure in relation to revenue can vary significantly from one company to another. Merck Healthcare's number is slightly elevated due to the acquisition of Prometheus. #pharmaceuticals #biotech #biopharma #drugdiscovery
-
-
Day 02: Strengthening Success and Pioneering Innovation at 𝐏𝐡𝐚𝐫𝐦𝐚 𝐀𝐬𝐢𝐚 𝟐𝟎𝟐𝟒 𝐃𝐚𝐲 𝟐 𝐚𝐭 *𝐏𝐡𝐚𝐫𝐦𝐚 𝐀𝐬𝐢𝐚 𝟐𝟎𝟐𝟒 is all about building on the momentum of Day 1 and pushing the boundaries of innovation. The energy continues to rise as industry leaders come together to share insights, explore new opportunities, and drive the pharmaceutical sector forward. Stay tuned as we dive deeper into groundbreaking discussions and transformative ideas shaping the future of pharma! #PharmaAsia #biggestpharmaevent #biggestpharma #ExpoCentreKarachi #pharma #Events
-
-
We're just over a week out from the release of this year's Pharmaceutical Innovation Index! What are the top trends that defined the world of Pharma in the last year? Share your perspective on the drivers that will shape the pharma landscape over the next year? Comment below! #pharma #PII #innovation https://lnkd.in/etpJ8Xcx
